Page last updated: 2024-09-05

anacardic acid and guttiferone e

anacardic acid has been researched along with guttiferone e in 1 studies

Compound Research Comparison

Studies
(anacardic acid)
Trials
(anacardic acid)
Recent Studies (post-2010)
(anacardic acid)
Studies
(guttiferone e)
Trials
(guttiferone e)
Recent Studies (post-2010) (guttiferone e)
177112020016

Protein Interaction Comparison

ProteinTaxonomyanacardic acid (IC50)guttiferone e (IC50)
Prostaglandin E synthaseHomo sapiens (human)0.3
Cytochrome P450 2B6Homo sapiens (human)0.5
Cytochrome P450 2C19Homo sapiens (human)0.5
Histone acetyltransferase p300Homo sapiens (human)5.375
Histone acetyltransferase KAT2BHomo sapiens (human)5

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, K; Chen, Y; Chen, Z; Ding, H; Han, J; Jiang, H; Liu, YC; Lu, T; Lu, W; Luo, C; Wang, C; Wang, J; Xiao, S; Xiong, H; Xu, P; Yang, Y; Yue, L; Zhang, C; Zhang, H; Zhang, Y; Zhou, B1

Other Studies

1 other study(ies) available for anacardic acid and guttiferone e

ArticleYear
Discovery and biological evaluation of thiobarbituric derivatives as potent p300/CBP inhibitors.
    Bioorganic & medicinal chemistry, 2018, 11-01, Volume: 26, Issue:20

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Discovery; Enzyme Inhibitors; Female; Humans; Leukemia; Mice, Nude; Molecular Docking Simulation; p300-CBP Transcription Factors; Thiobarbiturates; Transcriptome

2018